Loading
DM
Drugs Made In America Acquisition Corp. Stock: price and insider trades · United States
US·Mcap US$263.6M
No insider purchase over the last 90 days. The latest, by Stockwell Lynn, was filed 18 Feb 2025.
Drugs Made In America Acquisition Corp.: what insiders have been doing
Every trade that managers of Drugs Made In America Acquisition Corp. disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Drugs Made In America Acquisition Corp. in twelve months, the latest record being from 18 February 2025.
Looking back to 2025, when coverage begins, insiders filed 4 purchases and no sales.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
4 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleDrugs Made In America Acquisition LLC2 buys
Lynn Stockwell2 buys
Fundamental score
Ranked 12,365 of 23,476 companies
50.1
score / 100
Value42
Quality59
FCF yld-0.2%
Earn yld2.3%
EV/EBITDA·
ROE12%
Gross mgn58%
Net mgn0.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended December 2024 · cache
US$10.86
Analyst consensus
Income statement
RevenueUS$1B
Gross profitUS$602.9M58% margin
EBITDA-US$2.8M-0% margin
Net incomeUS$5.9M0.0% margin
Valuation
PER (trailing)60.3x
P/Book1.0x
Balance sheet & cash
Market capUS$263.6M
Total debtUS$662.3k
Free Cash Flow-US$539.2k
Profitability & ownership
ROE12.4%
ROA8.8%
% insiders23.6%
% institutions53.4%
Last declaration on 18 February 2025
Declarations8 total
30,000 sharesOrdinary sharesSEC:0001213900-25-015019:0
Canonical exit: 19 May 2025 (T+90)
30,000 sharesOrdinary sharesSEC:0001213900-25-015020:0
Canonical exit: 19 May 2025 (T+90)
400,000 sharesOrdinary sharesSEC:0001213900-25-010193:0
Canonical exit: 29 Apr 2025 (T+90)
400,000 sharesOrdinary sharesSEC:0001213900-25-010195:0
Canonical exit: 29 Apr 2025 (T+90)
100,000 sharesOrdinary sharesSEC:0001213900-25-009595:0
100,000 sharesOrdinary sharesSEC:0001213900-25-009600:0
100,000 sharesOrdinary sharesSEC:0001213900-25-009597:0
100,000 sharesOrdinary sharesSEC:0001213900-25-009602:0
8 of 8 declarations
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. is a special purpose acquisition company focused on the pharmaceutical sector. It aims to identify and acquire innovative companies within this field.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
